LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 28

Search options

  1. Article ; Online: Comparison of Healthcare Utilization Between Informal Caregivers and Non-Caregivers: An Analysis of the Health Information National Trends Survey.

    Shaffer, Kelly M / Nightingale, Chandylen L

    Journal of aging and health

    2019  Volume 32, Issue 5-6, Page(s) 453–461

    Abstract: Objective: ...

    Abstract Objective:
    MeSH term(s) Caregivers/statistics & numerical data ; Female ; Humans ; Male ; Middle Aged ; Patient Acceptance of Health Care/statistics & numerical data ; Patient Protection and Affordable Care Act ; Surveys and Questionnaires ; United States
    Language English
    Publishing date 2019-02-22
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 1045392-1
    ISSN 1552-6887 ; 0898-2643
    ISSN (online) 1552-6887
    ISSN 0898-2643
    DOI 10.1177/0898264319830262
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Cardiovascular health assessment in routine cancer follow-up in community settings: survivor risk awareness and perspectives.

    Weaver, Kathryn E / Dressler, Emily V / Smith, Sydney / Nightingale, Chandylen L / Klepin, Heidi D / Lee, Simon Craddock / Wells, Brian J / Hundley, W Gregory / DeMari, Joseph A / Price, Sarah N / Foraker, Randi E

    BMC cancer

    2024  Volume 24, Issue 1, Page(s) 158

    Abstract: Background: Guidelines recommend cardiovascular risk assessment and counseling for cancer survivors. For effective implementation, it is critical to understand survivor cardiovascular health (CVH) profiles and perspectives in community settings. We ... ...

    Abstract Background: Guidelines recommend cardiovascular risk assessment and counseling for cancer survivors. For effective implementation, it is critical to understand survivor cardiovascular health (CVH) profiles and perspectives in community settings. We aimed to (1) Assess survivor CVH profiles, (2) compare self-reported and EHR-based categorization of CVH factors, and (3) describe perceptions regarding addressing CVH during oncology encounters.
    Methods: This cross-sectional analysis utilized data from an ongoing NCI Community Oncology Research Program trial of an EHR heart health tool for cancer survivors (WF-1804CD). Survivors presenting for routine care after potentially curative treatment recruited from 8 oncology practices completed a pre-visit survey, including American Heart Association Simple 7 CVH factors (classified as ideal, intermediate, or poor). Medical record abstraction ascertained CVD risk factors and cancer characteristics. Likert-type questions assessed desired discussion during oncology care.
    Results: Of 502 enrolled survivors (95.6% female; mean time since diagnosis = 4.2 years), most had breast cancer (79.7%). Many survivors had common cardiovascular comorbidities, including high cholesterol (48.3%), hypertension or high BP (47.8%) obesity (33.1%), and diabetes (20.5%); 30.5% of survivors received high cardiotoxicity potential cancer treatment. Less than half had ideal/non-missing levels for physical activity (48.0%), BMI (18.9%), cholesterol (17.9%), blood pressure (14.1%), healthy diet (11.0%), and glucose/ HbA1c (6.0%). While > 50% of survivors had concordant EHR-self-report categorization for smoking, BMI, and blood pressure; cholesterol, glucose, and A1C were unknown by survivors and/or missing in the EHR for most. Most survivors agreed oncology providers should talk about heart health (78.9%).
    Conclusions: Tools to promote CVH discussion can fill gaps in CVH knowledge and are likely to be well-received by survivors in community settings.
    Trial registration: NCT03935282, Registered 10/01/2020.
    MeSH term(s) Female ; Humans ; Male ; Blood Pressure ; Breast Neoplasms ; Cardiovascular Diseases/epidemiology ; Cardiovascular Diseases/etiology ; Cholesterol ; Cross-Sectional Studies ; Follow-Up Studies ; Glucose ; Health Status ; Risk Assessment ; Risk Factors ; Survivors ; United States ; Clinical Trials as Topic
    Chemical Substances Cholesterol (97C5T2UQ7J) ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2024-01-31
    Publishing country England
    Document type Journal Article
    ZDB-ID 2041352-X
    ISSN 1471-2407 ; 1471-2407
    ISSN (online) 1471-2407
    ISSN 1471-2407
    DOI 10.1186/s12885-024-11912-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Defining Practice Capacity for Cancer Care Delivery to Adolescents and Young Adults in the Community Setting: 2022 Landscape Assessment Results.

    Beauchemin, Melissa P / Ji, Lingyun / Williams, AnnaLynn M / Nightingale, Chandylen L / Dressler, Emily V / Salsman, John M / Santacroce, Sheila J / Freyer, David R / Roth, Michael E / Parsons, Susan K

    Journal of adolescent and young adult oncology

    2024  

    Abstract: Background: ...

    Abstract Background:
    Language English
    Publishing date 2024-02-23
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2607978-1
    ISSN 2156-535X ; 2156-5333
    ISSN (online) 2156-535X
    ISSN 2156-5333
    DOI 10.1089/jayao.2023.0177
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Defining the Role of the Advanced Practice Provider Within the National Cancer Institute Community Oncology Research Program.

    Braun-Inglis, Christa M / Dressler, Emily V / Myers, Jamie S / Benson, Al B / Flannery, Marie / Good, Marjorie / Denicoff, Andrea / Berenberg, Jeffrey L / DeTroye, Alisha T / O'Brien, Bridget / Kottschade, Lisa / Omatsu, Dee Ann / Kittel, Carol A / Nightingale, Chandylen L / Foust, Melyssa / Lesser, Glenn J

    JCO oncology practice

    2024  Volume 20, Issue 2, Page(s) 239–246

    Abstract: Purpose: Oncology advanced practice providers (APPs), including nurse practitioners, clinical nurse specialists, physician assistants, and clinical pharmacists, contribute significantly to quality cancer care. Understanding the research-related roles of ...

    Abstract Purpose: Oncology advanced practice providers (APPs), including nurse practitioners, clinical nurse specialists, physician assistants, and clinical pharmacists, contribute significantly to quality cancer care. Understanding the research-related roles of APPs in the National Cancer Institute's (NCI) Community Oncology Research Program (NCORP) could lead to enhanced protocol development, trial conduct, and accrual.
    Methods: The 2022 NCORP Landscape Assessment Survey asked two questions about the utilization and roles of APPs in the NCORP.
    Results: A total of 271 practice groups completed the 2022 survey, with a response rate of 90%. Of the 259 nonpediatric exclusive practice groups analyzed in this study, 92% used APPs for clinical care activities and 73% used APPs for research activities. APPs most often provided clinical care for patients enrolled in trials (97%), followed by assistance with coordination (65%), presenting/explaining clinical trials (59%), screening patients (49%), ordering investigational drugs (37%), and consenting participants (24%). Some groups reported APPs as an enrolling investigator (18%) and/or participating in institutional oversight/selection of trials (15%). Only 5% of NCORP sites reported APPs as a site primary investigator for trials, and very few (3%) reported APPs participating in protocol development.
    Conclusion: Practice groups report involving APPs in clinical research within the NCORP network; however, opportunities for growth exists. As team-based care has enhanced clinical practice in oncology, this same approach can be used to enhance successful research. Suggested strategies include supporting APP research-related time, recognition, and education. The findings of this survey and subsequent recommendations may be applied to all adult oncology practices that participate in clinical research.
    MeSH term(s) Adult ; United States ; Humans ; National Cancer Institute (U.S.) ; Neoplasms/therapy ; Medical Oncology ; Quality of Health Care ; Nurse Practitioners
    Language English
    Publishing date 2024-01-04
    Publishing country United States
    Document type Journal Article
    ZDB-ID 3028198-2
    ISSN 2688-1535 ; 2688-1527
    ISSN (online) 2688-1535
    ISSN 2688-1527
    DOI 10.1200/OP.23.00501
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Processes for identifying caregivers and screening for caregiver and patient distress in community oncology: results from WF-1803CD.

    Nightingale, Chandylen L / Snavely, Anna C / McLouth, Laurie E / Dressler, Emily V / Kent, Erin E / Adonizio, Christian S / Danhauer, Suzanne C / Cannady, Rachel / Hopkins, Judith O / Kehn, Heather / Weaver, Kathryn E / Sterba, Katherine R

    Journal of the National Cancer Institute

    2023  Volume 116, Issue 2, Page(s) 324–333

    Abstract: Background: Despite their vital roles, informal caregivers of adult cancer patients are commonly overlooked in cancer care. This study describes processes for identifying cancer caregivers and processes for distress screening and management among ... ...

    Abstract Background: Despite their vital roles, informal caregivers of adult cancer patients are commonly overlooked in cancer care. This study describes processes for identifying cancer caregivers and processes for distress screening and management among caregivers and patients in the understudied community oncology setting.
    Methods: Supportive care leaders from the National Cancer Institute Community Oncology Research Program practices completed online survey questions regarding caregiver identification, caregiver and patient distress screening, and distress management strategies. We described practice group characteristics and prevalence of study outcomes. Multivariable logistic regression explored associations between practice group characteristics and caregiver identification in the electronic health record (EHR).
    Results: Most (64.9%, 72 of 111) supportive care leaders reported routine identification and documentation of informal caregivers; 63.8% record this information in the EHR. Only 16% routinely screen caregivers for distress, though 92.5% screen patients. Distress management strategies for caregivers and patients are widely available, yet only 12.6% are routinely identified and screened and had at least 1 referral strategy for caregivers with distress; 90.6% are routinely screened and had at least 1 referral strategy for patients. Practices with a free-standing outpatient clinic (odds ratio [OR] = 0.29, P = .0106) and academic affiliation (OR = 0.01, P = .04) were less likely to identify and document caregivers in the EHR. However, higher oncologist volume was associated with an increased likelihood of recording caregiver information in the EHR (OR = 1.04, P = .02).
    Conclusions: Despite high levels of patient distress screening and management, few practices provide comprehensive caregiver engagement practices. Existing patient engagement protocols may provide a promising platform to build capacity to better address caregiver needs.
    MeSH term(s) Adult ; Humans ; Caregivers ; Neoplasms/diagnosis ; Neoplasms/therapy ; Surveys and Questionnaires
    Language English
    Publishing date 2023-09-20
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2992-0
    ISSN 1460-2105 ; 0027-8874 ; 0198-0157
    ISSN (online) 1460-2105
    ISSN 0027-8874 ; 0198-0157
    DOI 10.1093/jnci/djad198
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Reducing Anxiety and Dyspnea via Device-Guided Breathing (RELAX): A Multi-Site Feasibility Study in Post-Treatment Lung Cancer Survivors at Community Cancer Clinics (WF-01213).

    Danhauer, Suzanne C / Dressler, Emily V / Brown, W Mark / Nightingale, Chandylen L / Brenes, Gretchen A / Petty, William J / Curtis, Amarinthia / Murkutla, Srujitha / Huang, Jocelin / Wagi, Cheyenne R / Lesser, Glenn J / Weaver, Kathryn E

    Integrative cancer therapies

    2023  Volume 22, Page(s) 15347354231164406

    Abstract: Introduction: Anxiety and dyspnea are 2 common symptoms for lung cancer survivors. Although research suggests decreasing respiration rate can reduce anxiety in several populations, potential benefits of device-guided breathing have not been studied in ... ...

    Abstract Introduction: Anxiety and dyspnea are 2 common symptoms for lung cancer survivors. Although research suggests decreasing respiration rate can reduce anxiety in several populations, potential benefits of device-guided breathing have not been studied in lung cancer survivors. This feasibility study (WF-01213) provides estimates of accrual, adherence, retention, and preliminary efficacy of 2 doses of a device-guided breathing intervention versus a usual breathing control group for improving self-reported anxiety and dyspnea in post-treatment lung cancer survivors.
    Methods: Stage I-IV lung cancer survivors were recruited through the NCI Community Oncology Research Program (NCORP) and randomized to 12 weeks of a device-guided breathing intervention (high dose vs. low dose) or control device. Self-reported outcomes (anxiety, depression, dyspnea, cancer-related worry, fatigue) were assessed at baseline, mid-intervention (Week-6), and post-intervention (Week-12).
    Results: Forty-six participants (ages 41-77, median = 65; 78% White) were randomized to the high-dose intervention (n = 14), low-dose intervention (n = 14), or control (n = 18) groups between July 2015 and September 2019. Study accrual rate was 0.92 per month for 50 months (projected accrual was 6.3/month). Fourteen participants (30%) withdrew early from the study, with almost half of those discontinuing at or immediately following baseline assessment. No participants were adherent with the intervention per protocol specifications. The proportion minimally adherent (using device at least 1x/week) was 43% (6/14), 64% (9/14), and 61% (11/18) for high-dose, low-dose, and control groups, respectively. Anxiety significantly decreased from baseline for all groups at Week 12. Adherence to the intervention was low across all treatment groups.
    Conclusions: This study did not establish feasibility of a community-based randomized trial of 2 doses of device-guided breathing and a control group using an identical-looking device for lung cancer survivors. In both the high-dose and control groups, there were significant improvements from baseline for anxiety and dyspnea. In the low-dose group, there were significant improvements from baseline for anxiety and depression. Ratings and feedback on the intervention were mixed (although leaned in a positive direction). Participants reported liking the feeling of relaxation/calm, helping others, breathing awareness, and music. Participants reporting liking least finding/making time to use the device, frustration with the device, and completing study forms.
    Trial registration: clinical trials id: NCT02063828, clinicaltrials.gov.
    MeSH term(s) Humans ; Adult ; Middle Aged ; Aged ; Feasibility Studies ; Cancer Survivors ; Depression/therapy ; Anxiety/etiology ; Anxiety/therapy ; Lung Neoplasms ; Dyspnea/etiology ; Dyspnea/therapy ; Lung ; Quality of Life
    Language English
    Publishing date 2023-04-26
    Publishing country United States
    Document type Randomized Controlled Trial ; Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2182320-0
    ISSN 1552-695X ; 1534-7354
    ISSN (online) 1552-695X
    ISSN 1534-7354
    DOI 10.1177/15347354231164406
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Endometrial cancer survivors' perceptions of their cardiovascular disease risk (results from WF-1804CD AH-HA).

    DeMari, Joseph A / Dressler, Emily V / Foraker, Randi E / Wells, Brian J / Smith, Sydney / Klepin, Heidi / Hundley, William G / Lesser, Glenn J / Shalowitz, David I / Nightingale, Chandylen L / Hernandez, Marcia / Weaver, Kathryn E

    Gynecologic oncology

    2023  Volume 174, Page(s) 208–212

    Abstract: Objective: Despite considerable burden of cardiovascular disease (CVD), data on endometrial cancer survivors' CVD perceptions are lacking. We assessed survivors' perspectives on addressing CVD risk during oncology care.: Methods: This cross-sectional ...

    Abstract Objective: Despite considerable burden of cardiovascular disease (CVD), data on endometrial cancer survivors' CVD perceptions are lacking. We assessed survivors' perspectives on addressing CVD risk during oncology care.
    Methods: This cross-sectional analysis utilized data from an ongoing trial of an EHR heart health tool (R01CA226078 & UG1CA189824) conducted through the NCI Community Oncology Research Program (NCORP, WF-1804CD). Endometrial cancer survivors post-potentially curative treatment were recruited from community practices and completed a pre-visit baseline survey, including American Heart Association Simple 7 CVD factors. Likert-type questions assessed confidence in understanding CVD risk, CVD risk perception, and desired discussion during oncology care. Medical record abstraction ascertained data on CVD and cancer characteristics.
    Results: Survivors (N = 55, median age = 62; 62% 0-2 years post-diagnosis) were predominately white, non-Hispanic (87%). Most agreed/strongly agreed heart disease poses a risk to their health (87%) and oncology providers should talk to patients about heart health (76%). Few survivors reported smoking (12%) but many had poor/intermediate values for blood pressure (95%), body mass index (93%), fasting glucose/A1c (60%), diet (60%), exercise (47%) and total cholesterol (53%). 16% had not seen a PCP in the last year; these survivors were more likely to report financial hardship (22% vs 0%; p = 0.02). Most reported readiness to take steps to maintain or improve heart health (84%).
    Conclusions: Discussions of CVD risk during routine oncology care are likely to be well received by endometrial cancer survivors. Strategies are needed to implement CVD risk assessment guidelines and to enhance communication and referrals with primary care. Clinical Trials #: NCT03935282.
    MeSH term(s) Female ; Humans ; Middle Aged ; Cancer Survivors ; Cardiovascular Diseases/epidemiology ; Cardiovascular Diseases/etiology ; Cross-Sectional Studies ; Endometrial Neoplasms/epidemiology ; Endometrial Neoplasms/therapy ; Neoplasms/therapy ; Survivors
    Language English
    Publishing date 2023-05-22
    Publishing country United States
    Document type Clinical Trial ; Journal Article
    ZDB-ID 801461-9
    ISSN 1095-6859 ; 0090-8258
    ISSN (online) 1095-6859
    ISSN 0090-8258
    DOI 10.1016/j.ygyno.2023.05.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Preferences for breast cancer survivorship care by rural/urban residence and age at diagnosis.

    Weaver, Kathryn E / Nightingale, Chandylen L / Lawrence, Julia A / Talton, Jennifer / Hauser, Sally / Geiger, Ann M

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

    2019  Volume 28, Issue 8, Page(s) 3839–3846

    Abstract: Purpose: Preferences for survivorship care among recently treated breast cancer survivors may vary by rural-urban residence and age, but potential differences have not been examined.: Methods: We conducted a cross-sectional survey of survivorship ... ...

    Abstract Purpose: Preferences for survivorship care among recently treated breast cancer survivors may vary by rural-urban residence and age, but potential differences have not been examined.
    Methods: We conducted a cross-sectional survey of survivorship preferences among women treated for non-metastatic breast cancer 6-24 months prior to recruitment.
    Results: We surveyed 203 women (66% response) with American Joint Committee on Cancer Stage I or II breast cancer. Rural residents comprised 36.5% of respondents (82.7% White, non-Hispanic; 52.5% < college education) and 29.6% were ≥ 65 years. More than 95% indicated that checking for recurrence, receiving additional treatment, evaluation of side effects, and identification of late effects were "very important" reasons for follow-up care. The most common topics identified as "very important" for survivorship care discussions were recommendations for healthy behaviors (65.3%), best sources for breast cancer information (65.3%), and effects on family (53.3%) and job (53.8%). Women 65 years and older preferred to discuss follow-up care at the time of diagnosis (p = 0.002), with younger women preferring during (32%) or after treatment (39.1%). Rural survivors were significantly more likely to identify follow-up care reasons not related to the initial breast cancer as "very important" than urban survivors, including screening for other cancers, and examinations or tests for non-cancer diseases (both p = 0.01).
    Conclusions: Survivorship care in accordance with national recommendations will likely be accepted by breast cancer survivors. Tailoring breast cancer survivorship care by timing, integration of primary care services, and specific psychosocial topics may best meet the needs of different ages and demographics.
    MeSH term(s) Age Factors ; Aged ; Breast Neoplasms/epidemiology ; Breast Neoplasms/mortality ; Breast Neoplasms/psychology ; Cancer Survivors/psychology ; Cross-Sectional Studies ; Female ; Humans ; Rural Population ; Surveys and Questionnaires ; Survivorship ; Urban Population
    Language English
    Publishing date 2019-12-13
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1134446-5
    ISSN 1433-7339 ; 0941-4355
    ISSN (online) 1433-7339
    ISSN 0941-4355
    DOI 10.1007/s00520-019-05134-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Cessation Attitudes and Preferences in Head and Neck Cancer Patients and Implications for Cessation Program Design: A Brief Report.

    Nightingale, Chandylen L / Sterba, Katherine R / Tooze, Janet A / King, Jessica L / Weaver, Kathryn E

    Global advances in health and medicine

    2019  Volume 8, Page(s) 2164956119847117

    Abstract: Introduction: This brief report examined prior cessation attempts, attitudes toward nicotine replacement therapy (NRT), and interests in cessation interventions among head and neck cancer (HNC) patients with a recent smoking history (current smokers and ...

    Abstract Introduction: This brief report examined prior cessation attempts, attitudes toward nicotine replacement therapy (NRT), and interests in cessation interventions among head and neck cancer (HNC) patients with a recent smoking history (current smokers and recent quitters).
    Methods: Forty-two HNC patients scheduled for major surgery who reported current or recent (quit <6 months) cigarette smoking participated. Participants completed a survey to assess smoking status, prior cessation attempts, attitudes toward NRT, and interest in and preferences for cessation interventions.
    Results: Patients attempted to quit smoking on average 3.2 times in the past 12 months. Most patients (65.8%) reported that NRT products help people quit, with 42.5% reporting ever using cessation aids/services. Most patients (81.8%) reported interest in a smoking cessation program. Current smokers and recent quitters reported similar cessation attempts, attitudes toward NRT, and interest in smoking cessation interventions.
    Discussion: Cancer center-based smoking cessation interventions are needed for current smokers and recent quitters maintaining cessation.
    Language English
    Publishing date 2019-04-30
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2709002-4
    ISSN 2164-9561 ; 2164-957X
    ISSN (online) 2164-9561
    ISSN 2164-957X
    DOI 10.1177/2164956119847117
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Information Technology and Telemedicine Services in Community Oncology Practices.

    Loh, Kah Poh / Wang, Ying / Yilmaz, Sule / Nightingale, Chandylen L / Parsons, Susan K / Braun-Inglis, Christa / Gada, Umang / Montes, Alexander / Magnuson, Allison / Culakova, Eva / Strause, Sarah / Kamen, Charles / Dressler, Emily / Mustian, Karen / Morrow, Gary / Mohile, Supriya

    JCO clinical cancer informatics

    2023  Volume 7, Page(s) e2300086

    Abstract: Purpose: We described information technology support and use of telemedicine for cancer care and research purposes at community oncology practices within the National Cancer Institute Community Oncology Research Program (NCORP).: Methods: We used ... ...

    Abstract Purpose: We described information technology support and use of telemedicine for cancer care and research purposes at community oncology practices within the National Cancer Institute Community Oncology Research Program (NCORP).
    Methods: We used data from the NCORP 2017 and 2022 Landscape Assessments. Separate logistic regression models were used to assess factors associated with the use of telemedicine for delivery of cancer care in 2017 and for research purposes in 2022 (cancer care delivery not assessed in 2022).
    Results: Information was available from 210 and 259 practice groups excluding pediatric-only groups in 2017 and 2022, respectively. In 2017, 30% of practice groups used telemedicine for delivery of cancer care; half of these (15% overall) could use telemedicine for research purposes. In 2022, telemedicine was used for research purposes in 73% of practice groups. In multivariable models, self-identifying as a safety-net hospital was associated with a lower odd of telemedicine use for delivery of cancer care (adjusted odds ratio [AOR], 0.39; 95% CI, 0.17 to 0.93), whereas affiliation with a designated critical access hospital was associated with a higher odd of telemedicine use for delivery of cancer care (AOR, 2.29; 95% CI, 1.10 to 4.76). Having a general survivorship clinic (AOR, 1.92; 95% CI, 1.04 to 3.54) and number of oncology providers (increase per 10 providers; AOR, 1.32; 95% CI, 1.05 to 1.65) were associated with telemedicine use for research purposes.
    Conclusion: Almost one third of NCORP practice groups used telemedicine for cancer care delivery in 2017. In 2022, there is high capacity among NCORP practices (almost three-quarters) to use telemedicine for research purposes, especially among practices with a general survivorship clinic and a greater provider number.
    MeSH term(s) Humans ; Child ; Information Technology ; Delivery of Health Care ; Telemedicine ; Neoplasms/diagnosis ; Neoplasms/therapy ; Medical Oncology
    Language English
    Publishing date 2023-08-03
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ISSN 2473-4276
    ISSN (online) 2473-4276
    DOI 10.1200/CCI.23.00086
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top